Advertisement
News
Subscribe to MDT Magazine News

Single gene controls jet lag

August 14, 2014 2:54 pm | by EurekAlert! | Comments

Scientists at the Salk Institute for Biological Studies have identified a gene that regulates sleep and wake rhythms. The discovery of the role of this gene, called Lhx1, provides scientists with a potential therapeutic target to help ...

Edison Nation Medical Announces Innovation Search To Improve Hazardous Waste Disposal in Hospitals & Healthcare Facilities

August 14, 2014 2:35 pm | by PR Newswire | Comments

CHARLOTTE, N.C., Aug. 14, 2014 /PRNewswire/ -- Edison Nation Medical, a health care innovation marketplace, today announced a worldwide search for ideas to improve the disposal of hazardous waste material in hospitals and healthcare facilities. The search seeks to address one of the...

Immune cell discovery could help to halt cancer spread

August 14, 2014 2:32 pm | by EurekAlert! | Comments

Melbourne researchers have revealed the critical importance of highly specialised immune cells, called natural killer cells, in killing melanoma cells that have spread to the lungs. These natural killer cells could be harnessed to hunt down and kill cancers that have spread in the body.

TOPICS:
Advertisement

Medical Device Development Tools (MDDT)

August 14, 2014 1:33 pm | by U.S. Food & Drug Administration | Comments

The FDA's Medical Device Development Tools (MDDT) program is a way for the FDA to qualify tools that medical device sponsors can use in the development and evaluation of medical devices. Qualification means that the FDA has evaluated the tool and...

El Camino Hospital Offers New FDA-Approved Transcatheter Heart Valve Therapy For Patients Who Are At High Risk To Undergo Open-Heart Surgery

August 14, 2014 11:33 am | by PR Newswire | Comments

MOUNTAIN VIEW, Calif., Aug. 14, 2014 /PRNewswire/ -- El Camino Hospital became one of the first hospitals in California to adopt a new minimally invasive system to treat patients with narrowed, failing aortic heart valves who are considered to be at high risk to undergo surgery. The...

Clinical trial tests COXEN model to predict best treatment for bladder cancer

August 14, 2014 10:47 am | by EurekAlert! | Comments

Imagine being able to match a cancer's genes to the best treatment. That's the promise of COXEN (CO eXpression ExtrapolatioN) – a computer program that looks at a panel of cancer genes in a patient's tumor to predict whether it will respond to chemotherapy. Now a clinical trial recently approved by the National Cancer Institute will open at the University of Colorado Cancer Center and nationally via the Southwest Oncology Group (SWOG to ...

TOPICS:

New material could enhance fast and accurate DNA sequencing

August 14, 2014 10:34 am | by EurekAlert! | Comments

DNGene-based personalized medicine has many possibilities for diagnosis and targeted therapy, but one big bottleneck: the expensive and time-consuming DNA-sequencing process. Now, researchers at the University of Illinois at Urbana-Champaign have found that nanopores in the material molybdenum disulfide (MoS2) could sequence DNA more accurately ...

TOPICS:

Novel chip-based platform could simplify measurements of single molecules

August 14, 2014 10:22 am | by EurekAlert! | Comments

Researchers at UC Santa Cruz have developed a new approach for studying single molecules and nanoparticles by combining electrical and optical measurements on an integrated chip-based platform. In a paper published July 9 in Nano Letters, the researchers reported using the device to distinguish viruses from similarly-sized nanoparticles with 100 percent fidelity.

TOPICS:
Advertisement

Entries open for ECN IMPACT Awards, celebrating excellence in electronics design

August 14, 2014 10:15 am | Comments

Companies from across the global electronics design landscape are invited to submit their stand-out products and services — in 24 categories — for consideration by a panel of judges for the 2015 ECN IMPACT Awards. The entry period opens today at www.ecnawards.com and ends January 19, 2015....

Bypass commands from the brain to legs through a computer

August 14, 2014 10:08 am | by EurekAlert! | Comments

Gait disturbance in individuals with spinal cord injury is attributed to the interruption of neural pathways from brain to the spinal locomotor center, whereas neural circuits locate below and above the lesion maintain most of their functions. An artificial connection that bridges the lost pathway and connects brain to spinal circuits has potential to ameliorate the functional loss.

TOPICS:

GE Healthcare to Use RTI Connext Middleware as Industrial Internet Transport for Medical Systems

August 14, 2014 8:31 am | by The Associated Press | Comments

Real-Time Innovations (RTI) , the Industrial Internet of Things communications platform company, today announced that GE Healthcare intends to use RTI's Connext™ Platform as the core communication for new generations of several products. The RTI Connext Platform allows ...

Caris Life Sciences Collaborates with GenoSpace to Enhance Data Mining Capabilities to Advance the Molecular Understanding of Cancer

August 14, 2014 7:34 am | by PR Newswire | Comments

IRVING, Texas, Aug. 14, 2014 /PRNewswire/ -- Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of precision medicine, today announced a collaboration with GenoSpace, a Massachusetts-based technology company that develops robust software solutions...

FDA Approves Lung Preservation Machine

August 13, 2014 4:11 pm | by The Associated Press | Comments

Federal health regulators have approved a novel device that can preserve donated lungs outside the body for possible transplantation into critically ill patients. The Food and Drug Administration said Tuesday that the approval of the XVIVO Perfusion System could lead to ...

TOPICS:

Patent examiners more likely to approve marginal inventions when pressed for time

August 13, 2014 4:02 pm | by EurekAlert! | Comments

Haste makes waste, as the old saying goes. And according to research from a University of Illinois expert in patent law, the same adage could be applied to the U.S. Patent and Trademark Office, where high-ranking examiners have a tendency to rubber-stamp patents of questionable merit due to time constraints.

TOPICS:

Stimuli-responsive drug delivery system prevents transplant rejection

August 13, 2014 3:56 pm | by EurekAlert! | Comments

Following a tissue graft transplant—such as that of the face, hand, arm or leg—it is standard for doctors to immediately give transplant recipients immunosuppressant drugs to prevent their body's immune system from rejecting and attacking the new body part. However, there are toxicities associated with delivering these drugs systemically, as well as side effects since suppressing the immune system can make a patient vulnerable to infection.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading